Summit Therapeutics Inc.

IPO

Committed to Optimizing Human Health

Public · Miami, United States · Founded 2003 · $500.0M raised

Headquarters
Miami, Florida
Employees
51–200
Founded
2003
Business Model
B2B
Website
smmttx.com
Total Funding
$500.0M
Last Round
$500.0M Corporate RoundOct 2025
Rounds
3
Type
Public

About

Summit Therapeutics is a biopharmaceutical oncology company focused on discovering and commercializing patient-friendly cancer therapies. Its lead investigational therapy, ivonescimab, is a novel bispecific antibody combining PD-1 and VEGF blockade, currently in multiple Phase 3 clinical trials for non-small cell lung cancer and colorectal cancer. The company licensed ivonescimab from Akeso Inc. in 2023 for the US, Canada, Europe, Japan, and other territories.

Summary

Summit Therapeutics Inc. is a Biotech company based in Miami, United States, founded in 2003. It has raised $500.0M in total across 3 rounds, most recently a $500.0M Corporate Round round in Oct 2025.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Corporate RoundCorporate RoundOct 2025

Sign up to see all 4 rounds

IPO through Corporate Round — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Summit Therapeutics Inc. on Indexed.vc
<a href="https://indexed.vc/companies/summit-therapeutics-inc"><img src="https://indexed.vc/api/badge/company/summit-therapeutics-inc" alt="Summit Therapeutics Inc. on Indexed.vc" width="260" height="76" /></a>